FDA Drug Recalls

Recalls / Class II

Class IID-0385-2017

Product

QUAD4 (PAP/PHEN/ALPROS/ATRO) 30 mg/3 mg/60 mcg/0.2 mg/mL Injectable, a) 2 mL and b) 5 mL vials, Compounded by Wells Pharmacy, Ocala, FL

Affected lot / code info
All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry. a) Known lot code: 04072016@8, 06272016@22, 09082016@29 b) Known lot code: 04142016@16, 04272016@8, 06102016@13, 07062016@29, 08052016@1.

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Wells Pharmacy Network LLC
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
1210 SW 33rd Ave, N/A, Ocala, Florida 34474-2853

Distribution

Quantity
114 vials and b) 1,017 vials
Distribution pattern
Nationwide

Timeline

Recall initiated
2016-09-21
FDA classified
2017-01-04
Posted by FDA
2017-01-11
Terminated
2021-07-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0385-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.